Its bioavailability is titrated moment-to-moment by the abundance of IGFBP-1 (which fluctuates with insulin and nutritional state), by IGFBP-3 and ALS levels (which are GH-dependent), and by IGFBP proteases that release bound IGF-1 in specific tissues
On timeline, NAD+ effects can be felt relatively quickly for some people, while many peptide driven changes build gradually
Lilly announced a new agreement with the Trump administration to expand access to its GLP-1 therapies, including Zepbound and orforglipron, offering the drugs to Medicare beneficiaries for $50 per month and through Medicaid programs starting in 2026
Reichrath J, Reichrath S
Monitoring for these overlapping effects is advisable, particularly in older adults who may be more sensitive to anticholinergic burden
Patients with active gallstones, prior cholecystitis, or bile duct obstruction face increased complications